XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Stock-Based Compensation  
Schedule of fair value assumptions of stock options

During the three months ended March 31, 2022 and 2021, we granted stock options at exercise prices equal to the quoted market price of our common stock on the grant date. The fair value of each option grant was estimated on the date of grant using Black-Scholes with the following weighted average assumptions:

March 31, 

    

2022

    

2021

Expected life (years)

4.2 - 5.2

3.5 - 6.1

Risk-free interest rate

 

2.1% - 2.3

%  

0.5% - 0.9%

Volatility

72.8% - 76.8

%  

64.4% - 80.8%

Dividend yield

 

0%

0%

Schedule of share-based payment awards

We recognize stock-based compensation cost on a straight-line basis over the vesting period. Stock-based compensation expense is recognized only for those awards that ultimately vest.

Total stock-based compensation expense related to all of our share-based payment awards is comprised of the following:

Three Months Ended March 31,

    

2022

    

2021

Cost of revenues

$

467

$

239

Selling, general and administrative

 

3,291

 

2,505

Engineering and development

 

367

 

246

$

4,125

$

2,990

Schedule of stock option activity

A summary of stock option activity is as follows:

Weighted-

Weighted-

Average

Average

Remaining

Aggregate

Number of

Exercise

Contractual

Intrinsic

    

Shares

    

Price/Share

    

Term (Years)

    

Value (1)

Outstanding — December 31, 2021

 

7,027,941

$

13.97

 

  

 

  

Granted (weighted-average fair value of $18.45 per share)

429,467

32.18

  

Exercised

 

(85,058)

 

4.71

 

  

 

Forfeited

 

(7,550)

 

54.26

 

  

 

Outstanding — March 31, 2022

 

7,364,800

$

15.09

 

5.7

$

158,839

Vested (exercisable) — March 31, 2022

 

5,624,632

$

9.99

 

5.2

$

143,609

Expected to vest after March 31, 2022 (unexercisable)

 

1,740,168

$

31.59

 

7.4

$

15,229

(1)Aggregate intrinsic value represents the difference between the exercise price of the option and the closing market price of our common stock on March 31, 2022, which was $34.91 per share.
Schedule of restricted stock unit activity

A summary of our restricted stock unit activity is as follows:

Weighted Average

Number of Restricted

 Fair Value per 

Stock Units

Share 

Outstanding – December 31, 2021

    

373,849

    

$

55.53

Granted

 

391,327

 

32.15

Share issuance

(58,395)

53.98

Forfeited

 

(12,894)

 

57.03

Outstanding – March 31, 2022

 

693,887

$

42.45